AVEO Aveo Pharmaceuticals Inc

AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics.

As of 05/12/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/12/2010
Outstanding shares:  34,360,775
Average volume:  739,427
Market cap:   $215,785,667
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    053588307
ISIN:        US0535883070
Sedol:      BKPX8S7
Valuation   (See tab for details)
PE ratio:   -6.39
PB ratio:   5.04
PS ratio:   35.85
Return on equity:   -100.82%
Net income %:   -591.19%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy